APOA2 and metabolic syndrome: Furthermore, an increased apoA-II concentration causes hypertriglyceridemia and lowers plasma HDL levels; this dyslipidemia induces glucose intolerance and the ensuing high blood glucose enhances the apoA-II transcription, leading to a vicious circle that may cause type 2 diabetes (T2D).